Detection of Superficial Zone Protein in Human and Animal Body Fluids by Cross-Species Monoclonal Antibodies Specific to Superficial Zone Protein
Authors:
- 1 June 2001
- journal article
- Published by SAGE Publications in Hybridoma
- Vol. 20 (3) , 149-157
Abstract
In this report we describe the purification of human superficial zone protein (SZP), the generation of cross-species monoclonal antibodies (MAbs) and the detection of this protein in human and animal body fluids. Human SZPs, used as immunizing antigens, were purified either from culture media of human cartilage organ cultures or from human synovial fluids. The immunizing antigens were mixed with RIBI adjuvant in one of three forms: nonmodified SZP, superficial zone protein-keyhole limpet hemocyanin conjugate (SZP-KLH), or a mixture of superficial zone protein and hyaluronic acid (SZP-HA). A panel of MAbs including GW4.23, S6.79, S13.52, S13.233, and S17.109 were generated and characterized. Monoclonal antibody (MAb) S6.79, an IgG2b with K(D) 3.14 x 10(-9) M from SZP-KLH immunization, is of particular interest. It reacts strongly to a large molecular weight form of SZP in both enzyme-linked immunosorbent assay (ELISA) and Western blotting. It stains the most superficial layer of articular cartilage in immunohistochemistry, whereas the middle and deep zones of cartilage are not stained. When MAb S6.79 was applied to Western blots of human body fluids, a strong 345-kDa band was detected in samples of synovial fluid and weaker bands of similar size were detected in samples of plasma and serum. MAb S6.79 also showed cross-species immunoreactivity with SZP in samples of synovial fluids harvested from bovine, dog, guinea pig, and rabbit, as demonstrated by Western blotting and antibody absorption experiments. This cross-species MAb will be a useful tool in human and animal model studies for monitoring SZP levels and tissue distribution. It may help define the roles of SZP in normal articular joints and may be of diagnostic or prognostic value for the measurement of SZP in pathological conditions such as osteoarthritis, rheumatoid arthritis, and camptodactyly-arthropathy-coxa vara-pericarditis.Keywords
This publication has 23 references indexed in Scilit:
- The role of transforming growth factor (TGF)-β, insulin-like growth factor (IGF)-1, and interleukin (IL)-1 in osteoarthritis and aging of jointsExperimental Gerontology, 1999
- New potential therapeutic goals: subchondral bone and progression of osteoarthritisOsteoarthritis and Cartilage, 1999
- Osteophyte formation in osteoarthritisOsteoarthritis and Cartilage, 1999
- Subchondral bone morphological and biochemical alterations in osteoarthritisOsteoarthritis and Cartilage, 1999
- Age-related changes in the synthesis of link protein and aggrecan in human articular cartilage: implications for aggregate stabilityBiochemical Journal, 1999
- Suppression of cartilage matrix gene expression in upper zone chondrocytes of osteoarthritic cartilageArthritis & Rheumatism, 1997
- The superficial layer of human articular cartilage is more susceptible to interleukin‐1–induced damage than the deeper layersArthritis & Rheumatism, 1996
- Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration.Journal of Clinical Investigation, 1995
- Mechanical and biochemical changes in the superficial zone of articular cartilage in canine experimental osteoarthritisJournal of Orthopaedic Research, 1994
- Proteoglycans of articular cartilage: Changes in aging and in joint diseaseSeminars in Arthritis and Rheumatism, 1990